Growing Little PEAPODS Study
Recruiting
Observational Study
Premature Birth
Premature Infant
Premature
Intrauterine Growth Restriction
Small for Gestational Age at Delivery
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 22 Weeks – 32 Weeks
- Sex
- Any
- Study type
- Observational
- Participants needed
- 120 (estimated)
- Sponsor
- University of Wisconsin, Madison · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to learn more about how the food and nutrition babies receive while in the Neonatal Intensive Care Unit (NICU) influences their ability to gain weight and fat-free mass, and their future growth and development.
Participants will:
* have body growth measurements collected using the PEAPOD device
* have nutritional information collected, and
* be followed for neu…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Neonate Inclusion Criteria:
* Born inpatient at Meriter Hospital, Inc. at or above 22 gestational weeks. Upper limit is 32 weeks 6 days GA (possible gestational age range from 22w0d-32w6d)
Neonate Exclusion Criteria:
* Known genetic condition that impacts neurodevelopmental outcomes or brain stru…
Contacts